We would like to thank Progenosis who generously supplied us with non-phosphorylated and phosphorylated Tau proteins
        
        
            
                CLAVAGUERA F., BOLMONT T., CROWTHER R. A., ABRAMOWSKI D., FRANK S., PROBST A., FRASER G., STALDER A. K., BEIBEL M., STAUFENBIEL M., JUCKER M., GOEDERT M., TOLNAY M. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol., 11(7) : 909-901.    
    
DAVID D. C., LAYFIELD R., SERPELL L., NARAIN Y., GOEDERT M., SPILLANTINI M. G. (2002). Proteasomal degradation of tau protein. Journal of Neurochemistry, 83: 176-185.    
    
DUJARDIN S., LECOLLE K., CAILLIEREZ R., BEGARD S., ZOMMER N., LACHAUD C., CARRIER S., DUFOUR N., AUREGAN G., WINDERINCKX J., HANTRAYE P., DEGLON N., COLIN M., BUEE L. (2014). Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications, 2:14.     
    
FLACH K., HILBRICH I., SCHIFFMANN A., GARTNER U., KRUGER M., LEONHARDT M., WASCHIPKY H., WICK L., ARENDT T., HOLZER M. (2012). Tau Oligomers Impair Artificial Membrane Integrity and Cellular Vability. Journal of Biological Chemistry, 287(52):43223-43233.    
    
FROST B., JACKS R. L., DIAMOND M. I. (2009). Propagation of Tau Misfolding from the Outside to the Inside of a Cell. Journal of Biological Chemistry, 284:12845-12852.    
    
GIANNACOPOULOS P. (2003). Tangles and neuron numbers but not amyloid load predict cognitive status in Alzheimer's disease. Annals of General Hospital Psychiatry, 2: S18.    
    
GUO J. L., LEE V. M. Y. (2013). Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Letters, 587: 717-723.    
    
LASAGNA-REEVES C. A., CASTILLO-CARRANZA D. L., SENGUPTA U., CLOS A. L., JACKSON J. R., KAYED R. (2011). Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Molecular Neurodegeneration, 6:39.    
   
LIU L., DROUET V., WU J. W., WITTER M. P., SMALL S. A., CLELLAND C., DUFF K. (2012). Trans-synaptic Spread of Tau Pathology In Vivo. Plos One, 7(2): e31302.    
    
MEDINA M., AVILA J. (2014). New perspectives on the role of tau in Alzheimer’s disease. Implications for therapy. Biochemical Pharmacology, 88 : 540-547.    
    
MICHEL C. H., KUMAR S., PINOTSI D., TUNNACLIFFE A., ST.GEORGE-HYSLOP P., MANDELKOW E., MANDELKOW E-M., KAMINSKI C. F., KAMINSKI SCHIERLE G. S. (2013). Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology. Journal of Biological Chemistry, 289:956-967.    
    
SANTA-MARIA I., VARGHESE M., KSIZAK-REDING H., DZHUN A., WANG J., PASINETTI M. (2012). Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. The Journal of Biological Chemistry, 287: 20522-20533.    
    
SAMAN S., KIM W., RAYA M., VISNICK Y., MIRO S., SAMAN S., JACKSON B., MCKEE AC., ALVAREZ VE., LEE NC., HALL GF. (2011). Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. The Journal of Biological Chemistry, 287(6): 3842-3849.    
    
TAI H-C., WANG B. Y., SERRANO-POZO A., FROSCH M. P., SPIRES-JONES T. L., HYMAN B. T. (2014) Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease. Acta Neuropathologica communications, 2: 146.    
    
WANG Y., MARTINEZ-VICENTE M., KRUGER U., KAUSHIK S., WONG E., MANDELKOW E-M., CUERVO A-M., MANDELKOW E. (2009). Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Human Molecular Genetics, 18(2): 4153-4170.